Evidence map›Paper›PMID 18754690›Full record

ArticleNano letters2008

Nanoparticles for gene transfer to human embryonic stem cell colonies.

Jordan J Green, Betty Y Zhou, Maisam M Mitalipova, Caroline Beard, Robert Langer, Rudolf Jaenisch, Daniel G Anderson

Open access · greenAbstract read
In one paragraph

Article in Nano letters, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Cell-drug conjugates.Nature biomedical engineering · 2024
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Therapeutic angiogenesis using genetically engineered human endothelial cells.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jordan J GreenDepartment of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
Betty Y Zhou
Maisam M Mitalipova
Caroline Beard
Robert Langer
Rudolf Jaenisch
Daniel G Anderson
Whitehead Institute for Biomedical Research · USMassachusetts Institute of Technology · US

Funding

CONTROLLED RELEASE OF MACROMOLECULESR01EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL, TRAVERSO, CARLO GIOVANNI · 2002 to 2021
$6.1M
Controlled Release of MacromoleculesR37EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 2008 to 2017
$3.9M
High-Throughput Craniofacial tissue engineeringR01DE016516 · NIDCR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 2005 to 2014
$3.8M
NIBIB NIH HHS EB 00244NIBIB NIH HHS R01 EB000244NIBIB NIH HHS R37 EB000244NIDCR NIH HHS R01 DE016516NIDCR NIH HHS R01-DE016516-03
6 · The paper itself

Abstract

We develop biodegradable polymeric nanoparticles to facilitate nonviral gene transfer to human embryonic stem cells (hESCs). Small (approximately 200 nm), positively charged (approximately 10 mV) particles are formed by the self assembly of cationic, hydrolytically degradable poly(beta-amino esters) and plasmid DNA. By varying the end group of the polymer, we can tune the biophysical properties of the resulting nanoparticles and their gene-delivery efficacy. We created an OCT4-driven GFP hES cell line to allow the rapid identification of nanoparticles that facilitate gene transfer while maintaining an hESC undifferentiated state. Using this cell system, we synthesized nanoparticles that have gene delivery efficacy that is up to 4 times higher than that of the leading commercially available transfection agent, Lipofectamine 2000. Importantly, these materials have minimal toxicity and do not adversely affect hESC colony morphology or cause nonspecific differentiation.

Indexed as

Gene Transfer TechniquesAnimalsBiocompatible MaterialsCationsCell DifferentiationEmbryonic Stem CellsFlow CytometryGenetic TechniquesGenetic VectorsGreen Fluorescent ProteinsHydrolysisMiceNanotechnologyOctamer Transcription Factor-3PolymersBiocompatible MaterialsCationsGreen Fluorescent ProteinsOctamer Transcription Factor-3PolymersPOU5F1 protein, human

Identifiers

PMID18754690
PMCPMC3814161
OpenAlexW2046312023

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.